Impact of changes in tricuspid regurgitation on clinical outcomes following mitral valve teer compared to guideline-directed medical therapy: a sub-analysis of the COAPT trial
Event: EuroEcho 2021
Topic: Valvular Heart Disease
Session: New insights into the challenging tricuspid valve
ESC 365 is supported by
